Topic

Articles

This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.

Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling Approaches

Insights on conducting global DCTs and guidance for how best to plan and execute effective eCOA strategies.

Perspectives and Guidance for Effective eCOA in Global DCTs

Consultant, International Drug Development Institute (IDDI)

Using the promising-zone approach can salvage an underpowered trial.

Sample Size Re-Estimation as an Adaptive Design 

Industry set to make choice on whether COVID-19 trials are the new standard.

The Future of Clinical Trial Design Looks Bright

Strategies and considerations for adopting decentralized clinical trials. 

Five Key Considerations for Designing and Implementing Decentralized Clinical Trials

A look at some of the leading causes of study failure and explain how improving medication adherence could be the key to risk mitigation.

Mitigate Risk By Managing Medication Adherence

The success of the decentralized model hinges on coordination between stakeholders across the supply chain to ensure that date is secure, medication is delivered on time, and in proper condition.

Direct-to-Patient: At-Home Clinical Trials Are Here to Stay

COVID-19 forces life sciences industry to make long overdue changes.

5 Ways DCTs Can Positively Impact Trial Diversity

Pandemic-forced move to remote monitoring calls for industry-wide collaboration.

Maximizing the Value of Remote Monitoring

Upcoming Clinical Trials Day allows industry to look back—and forward.